Browsing: Markets

Markets
Pitney Bowes Announces Pricing Adjustment as Ecommerce Demand Continues to Surge Ahead of 2020 Peak

Pitney Bowes Inc. (NYSE:PBI), a global technology company that provides commerce solutions in the areas of ecommerce, shipping, mailing and financial services, today announced pricing adjustments for its domestic and cross-border delivery and returns services for the peak holiday shipping season. The pricing changes will be applied as flat, easy-to-understand, per-parcel adjustments, not to exceed $1.50 per parcel. “Our clients rely on Pitney Bowes to help anticipate and manage their logistics costs. We don’t take that responsibility lightly and the challenges of the pandemic have not altered our approach to simple and transparent pricing,” said Gregg Zegras, Executive Vice President and President of Global Ecommerce at Pitney Bowes. “We have worked directly with our clients to review and revise volume projections and examine the realities of our market. Based on that analysis we are introducing a simple, reasonable, and temporary peak rate adjustment not to exceed $1.50 per parcel across all of our ecommerce delivery and returns services.” While the current expansion of ecommerce has been fruitful for online commerce, it has also created challenges as shipping costs are rising ahead of what is expected to be the largest online holiday shopping season in history. Major carriers have

Markets
Genprex Appoints William E. Gannon, Jr., MD, MBA, as Vice President of Regulatory Affairs

Genprex, Inc. (“Genprex” or the “Company”) (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced the appointment of William Gannon, MD, MBA as the Company’s Vice President of Regulatory Affairs. Dr. Gannon brings more than 30 years of experience in the biotech and pharmaceutical industries to the Company, with expertise in clinical development, regulatory affairs and commercialization of products, and a strong background in oncology and gene therapy. “We are pleased to have Dr. Gannon join our team. His extensive experience in the management of clinical trials, from designing trials to building operational teams, will be an important asset for us as we work toward initiating our upcoming trials and seeing them through to successful completion,” said Rodney Varner, Genprex’s Chairman and Chief Executive Officer. Dr. Gannon will be responsible for managing the Company’s regulatory affairs for its upcoming clinical trials that combine its lead drug candidate, GPX-001 for non-small cell lung cancer (NSCLC), with AstraZeneca’s targeted therapy Tagrisso® (osimertinib) and with immunotherapy Keytruda® (pembrolizumab). Genprex received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for use of GPX-001 in combination with Tagrisso in late-stage

Markets
USA Technologies to Release Fourth Quarter and Full Year Results on September 10, 2020

USA Technologies, Inc. (OTC:USAT) (“USAT” or the “Company”), a cashless payments and software services company that provides end-to-end technology solutions for the self-service retail market, today announced that management will host a webcast and conference call to discuss 2020 fourth quarter and full year results on September 10, 2020 at 4:30 p.m. Eastern Time. A press release highlighting the financial results will be issued at approximately 4:00 p.m. Eastern Time the same day. To participate in the conference call, please dial +1 (866) 433-2471, approximately 10 minutes prior to the call. International callers should dial +1 (224) 357-2186. Please reference conference ID #6485605. A live webcast of the conference call will be available at: https://usatechnologiesinc.gcs-web.com/events-and-presentations. Please access the website 15 minutes prior to the start of the call to download and install any necessary audio software. A telephone replay of the conference call will be available from 7:30 p.m. Eastern Time on September 10, 2020 until 7:30 p.m. Eastern Time on September 13, 2020 and may be accessed by calling +1 (855) 859-2056 (domestic dial-in) or +1 (404) 537-3406 (international dial-in) and reference conference ID #6485605. An archived replay of the conference call will also be

Markets
Cohu Provides Business Update for the Third Quarter Ending September 26, 2020

Cohu, Inc. (NASDAQ: COHU), a global leader in back-end semiconductor equipment and services, today provided a business update and an upward revision to its fiscal third quarter 2020 guidance: Cohu expects a net neutral to positive impact from the newly introduced U.S. export restrictions to Huawei and expanded list of affiliated companies, as market share and demand is expected to shift to other customers. Order forecast has improved through third quarter with continued positive customer momentum in mobility and strong demand for Cohu’s RF testers. Cohu now expects third quarter revenue at the high-end of guidance at approximately $146 million. The company commenced reduction of the term loan B debt associated with the financing of the Xcerra acquisition in October 2018, recently reducing such debt by $17.3 million. Luis Müller, President and Chief Executive Officer of Cohu, commented, “We are encouraged by our customers’ acceptance and ramp of our RF test solutions, and this drives our increased optimism about near-term business conditions.” About Cohu: Cohu is a leading supplier of semiconductor test and inspection handlers, micro-electro mechanical system (MEMS) test modules, test contactors and thermal sub-systems used by global semiconductor manufacturers and test subcontractors. Forward Looking Statements:

Markets
Aimmune Therapeutics Enters Definitive Agreement with Sociétés des Produits Nestlé S.A., Part of Nestlé Health Science

Aimmune Therapeutics Inc. (Nasdaq: AIMT), a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies, today announced that it has entered into a definitive agreement for Sociétés des Produits Nestlé, S.A. to acquire Aimmune for $34.50 per share in an all-cash transaction, implying a fully-diluted equity value of $2.6 billion. Sociétés des Produits Nestlé, S.A. is a part of Nestlé Health Science (NHSc) and a wholly owned subsidiary of Nestlé S.A. The agreement was unanimously approved by all of the independent members of the Board of Directors of Aimmune. Greg Behar, CEO of Nestlé Health Sciences and an Aimmune Director, abstained due to his position with Nestlé Health Science. “The agreement with Nestlé recognizes the value created by years of commitment and dedication to our mission by the team at Aimmune. Delivering PALFORZIA, the world’s first treatment for food allergy, is a game-changing proposition in the biopharmaceutical industry and is transformative for the lives of millions of people living with potentially life-threatening peanut allergy,” said Jayson Dallas, MD, President and Chief Executive Officer of Aimmune. “This acquisition provides strong value for our shareholders and ensures a level of support for PALFORZIA and our pipeline that will further

Markets
Mannatech Declares Increased Second Quarter 2020 Dividend

Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, announced that its Board of Directors declared a cash dividend of $0.16 per share of common stock, payable on Tuesday, September 29, 2020, to shareholders of record at the close of business on Tuesday, September 15, 2020. The dividend reflects a 28.0% increase in the quarterly dividend amount and demonstrates a commitment to rewarding shareholders and encouraging long-term investment in Mannatech’s common stock. Alfredo “Al” Bala, President and CEO of Mannatech, said, “Mannatech is fully committed to delivering value to our shareholders, as confirmed by this dividend increase.” About Mannatech Mannatech, Incorporated is committed to transforming lives through the development of high quality integrated health, weight management, fitness and skin care products distributed through its global network of independent associates and members. The company has been operating for more than 25 years with operations in 25 markets^. For more information, visit Mannatech.com. ^ Mannatech operates in China under a cross-border e-commerce platform that is separate from its network marketing model. Please Note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act

Markets
Aptorum Group Interview to Air on Bloomberg International on the RedChip Money Report

Regulatory News: Aptorum Group Limited (NASDAQ: APM), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, today announced an interview with its President, Daniel Lui, will air on The RedChip Money Report television program. The interview will air Sunday, August 30, at 6 p.m. local time on Bloomberg International, available in 100+ million homes across Europe. In the exclusive interview, Lui provides an overview of the Company’s development pipeline and near-term commercialization efforts. To view the interview segment, please visit: https://youtu.be/rjvqZfs5zqk The interview will also air in the US on the Action Channel on Sunday August 30 at 11 a.m. ET and is available via live stream on American Business TV. “The RedChip Money Report” delivers insightful commentary on small-cap investing, interviews with Wall Street analysts, financial book reviews, as well as featured interviews with executives of public companies. About Aptorum Group Aptorum Group Limited (Nasdaq: APM) is a pharmaceutical company dedicated to developing and commercializing novel therapeutics to tackle unmet medical needs. Aptorum Group’s current drug pipeline includes indications in orphan diseases, infectious diseases and metabolic diseases and a number of which are targeted to enter clinical trial

Markets
Elastic to Participate in Upcoming Investor Conferences

Elastic (NYSE: ESTC) (“Elastic”), the company behind Elasticsearch and the Elastic Stack, announced that its management team will present at the following virtual investor conferences. Citi 2020 Global Technology Conference on Wednesday, September 9, 2020, at 10:30 a.m. PT / 1:30 p.m. ET Jefferies 2020 Virtual Software Conference on Monday, September 14, 2020, at 8:00 a.m. PT / 11:00 a.m. ET A live webcast of each event will be available on Elastic’s Investor Relations page at ir.elastic.co. Replays of the webcasts will be available for 60 days. About Elastic Elastic is a search company built on a free and open heritage. Everyone can get started with Elastic products and solutions quickly and frictionlessly. Elastic offers three solutions for enterprise search, observability, and security built on one technology stack that can be deployed anywhere. From finding documents to monitoring infrastructure to hunting for threats, Elastic makes data usable in real time and at scale. Founded in 2012, Elastic is a distributed company with Elasticians around the globe. Learn more at elastic.co. Elastic and associated marks are trademarks or registered trademarks of Elastic N.V. and its subsidiaries. All other company and product names may be trademarks of their respective

Markets
Comcast to Participate in Goldman Sachs Investor Conference

On Tuesday, September 15, 2020, Brian L. Roberts, Chairman and Chief Executive Officer of Comcast Corporation (Nasdaq: CMCSA), will participate in the Goldman Sachs 29th Annual Communacopia Virtual Conference. A live webcast of the event will be available on the Company’s Investor Relations website at www.cmcsa.com on Tuesday, September 15, 2020 at 9:40 A.M. Eastern Time. An on-demand replay will be available shortly after the conclusion of the presentation. To automatically receive Comcast financial news by e-mail, please visit www.cmcsa.com and subscribe to E-mail Alerts. About Comcast Corporation Comcast Corporation (Nasdaq: CMCSA) is a global media and technology company with three primary businesses: Comcast Cable, NBCUniversal, and Sky. Comcast Cable is one of the United States’ largest high-speed internet, video, and phone providers to residential customers under the Xfinity brand, and also provides these services to businesses. It also provides wireless and security and automation services to residential customers under the Xfinity brand. NBCUniversal is global and operates news, entertainment and sports cable networks, the NBC and Telemundo broadcast networks, television production operations, television station groups, Universal Pictures, and Universal Parks and Resorts. Sky is one of Europe’s leading media and entertainment companies, connecting customers to a

Markets
Xylem Delivers More Than 100,000 Face Shields to Front-line Workers

Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today announced it manufactured and delivered through Xylem partners more than 100,000 protective face shields in Europe and the United States in response to the COVID-19 pandemic. The initiative leveraged internal manufacturing capabilities including three-dimensional printing and injection molding. Beginning in March, Xylem partners helped deliver the face shields to healthcare facilities on the front lines of critical care and to utilities with water operators working to keep essential services flowing in local communities. To distribute the face shields, Xylem Watermark, Xylem’s corporate social responsibility program, worked with partner organizations around the world including but not limited to: Wallace Eannace Associates helped deliver face shields to healthcare facilities in New York and New Jersey, areas hard-hit by the virus. Frank P. Langley, Co., Inc., delivered face shields to healthcare facilities in Upstate NY. Hydronic Technology, Inc. delivered PPE to healthcare facilities in their home states of Louisiana and Mississippi. James M. Pleasants Co., Inc. provided face shields to healthcare workers in North Carolina. R.L. Deppman Company delivered PPE to six health systems across Michigan and Northern Ohio. Országos Baleseti

1 50 51 52 53